Medical Device Agency Franchise for EEG & Neurodiagnostic Distributors

About NCC Medical Group

NCC Medical Group is an internationally recognized manufacturer specializing in neurodiagnostic and neuro-monitoring technologies. Since its establishment in 1997, NCC has focused on advancing medical innovation in the fields of EEG, EMG, polysomnography and intraoperative neuro-monitoring. Today the company supports hospitals, neurological centers and research institutions worldwide with reliable diagnostic solutions and professional technical services.

NCC has been recognized as a National “Little Giant” enterprise under the SRDI program, a prestigious designation awarded to companies that demonstrate strong technological innovation and specialized manufacturing capabilities. The SRDI designation reflects NCC’s commitment to developing proprietary technologies and maintaining leadership in the neurophysiology equipment industry.

The company’s research and manufacturing operations are located in Shanghai, China, where advanced engineering teams focus on neurophysiology technology development and precision production. The Shanghai facility integrates product design, electronics development, manufacturing and quality control into a single innovation ecosystem. This integrated approach allows NCC to maintain strict quality standards while continuously improving product performance and reliability.

To ensure global quality compliance and international business coordination, NCC operates a strategic hub in Singapore. The Singapore office oversees international regulatory compliance, quality assurance and global market coordination. This dual-center structure allows NCC to combine strong engineering capabilities with international operational management.

NCC’s product portfolio includes EEG systems, EMG devices, polysomnography systems, intraoperative neuro-monitoring solutions and a full range of neurodiagnostic consumables. These technologies are widely used in neurology departments, sleep laboratories, operating rooms and research institutes. By integrating hardware innovation with intelligent software systems, NCC provides comprehensive diagnostic solutions that help clinicians obtain accurate neurological data.

Over the years NCC has built a strong global presence. Its technologies are now used in more than 50 countries, and more than 5,000 hospitals across China rely on NCC solutions for neurological diagnostics and surgical monitoring. The company has established partnerships with hospitals and distributors throughout Southeast Asia, Europe, the Americas, Australia and Africa.

To support clinical users and distribution partners, NCC operates 31 training and technical support centers across China. These centers provide professional education for clinicians, biomedical engineers and distributor technicians. Through the NCC Innovation Academy and the NeuGuard Service Platform, the company offers continuous professional education, technical training and application guidance.

NCC is actively expanding its global distributor network through the Medical Device Agency Franchise program. By collaborating with regional partners, NCC aims to deliver advanced neurodiagnostic technologies to healthcare providers worldwide while ensuring strong local service support.

The mission of NCC Medical Group is to safeguard life and health by enabling safer surgeries, more precise neurological diagnostics and improved patient care. Through innovation, collaboration and professional training, NCC continues to support medical professionals in delivering high-quality healthcare services.